SCHEMBL4496903

SCHEMBL4496903

COc1cccc(Cn2c(C)cc(O)cc2=O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 4/20 0.55
CD74 P04233 3/20 0.55
CMA1 P23946 1/20 0.55
KMT2A Q03164 2/20 0.54
MAPT P10636 2/20 0.53
LMNA P02545 3/20 0.51
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
POLB P06746 2/20 0.50
CYP1A2 P05177 4/20 0.49
CYP3A4 P08684 4/20 0.49
TSHR P16473 4/20 0.49
CYP2C19 P33261 4/20 0.49
CYP2D6 P10635 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TP53 P04637 2/20 0.49
CYP2C9 P11712 2/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4376098 0.85 ALDH1A1 (0.57) CMA1KMT2AMAPTLMNAPOLB
SCHEMBL4392970 0.81 LMNA (0.60) KMT2AMAPTLMNAPOLBTSHR
SCHEMBL4378973 0.81 KDM4E (0.55) MAPTLMNAPOLBALDH1A1IDH1
SCHEMBL4510969 0.78 CMA1 (0.51) MIFCD74CMA1KMT2AMAPT
SCHEMBL4513012 0.78 CMA1 (0.51) MIFCD74CMA1KMT2AMAPT
SCHEMBL19048416 0.78 ALDH1A1 (0.62) MIFCD74CMA1KMT2AMAPT
SCHEMBL4516793 0.77 POLB (0.48) KMT2AMAPTLMNAPOLBTSHR
SCHEMBL4384316 0.77 LMNA (0.50) KMT2ALMNAPOLBALDH1A1MEN1
SCHEMBL461145 0.77 MAPT (0.59) MIFCD74CMA1KMT2AMAPT
SCHEMBL4512432 0.76 POLB (0.47) KMT2AMAPTLMNAPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PFIZER INC. 2009-10-29 US disclosed
EP-1987022-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES Pfizer Products Inc. (US) 2008-11-05 EP disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed
WO-2007091176-A1 PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270350-A1 Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives PDXK, UMPS, CDK2 MIF 1454/4885CD74 3522/4885CMA1 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.